Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,063.6
-12.8 (-0.42%)

 

  • STI Straits Times Index
    3,063.6
    -12.8 (-0.42%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,529.6
    -9.7 (-0.63%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,125.7
    -385.3 (-1.57%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,613.1
    -29.2 (-0.80%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,248.8
    609.4 (2.06%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,139.1
    -3.6 (-0.06%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 767.9M
  • Value: 908.8M
  • Rise: 111
  • Fall: 190
  • Unch: 454

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.081-
Singtel2.510+0.030
ThaiBev0.655-
CapitaLandInvest3.350-0.050
HS Optimus0.004-
VCPlus0.025-
Shen Yao0.004-
Hatten Land0.059-0.003
YZJ Shipbldg SGD1.430+0.020
Genting Sing0.740-0.005

World Indices

World Indices
Name Last Change
Nasdaq 15,052.2 +155.4
HSI 24,155.4 -355.6
HSCEI 8,590.9 -142.8
Jakarta 6,144.8 +2.1
Nikkei 225 30,248.8 +609.4
SSE Comp 3,613.1 -29.1
Shanghai A 3,786.7 -30.5
Shanghai B 274.7 -4.0
KOSPI 3,125.2 -2.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EXICURE INC EXICURE INC
Updated on 23 Sep 2021 (End of trading day)
Last (USD): 1.310 Change: +0.030 High: 1.320 Remarks: -
Change (%): +2.34 Low: 1.290
Open 1.300 Yesterday's Close 1.28
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 187,314 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.27997 Trailing EPS (USD) e -0.54765 NAV (USD) b 0.4159
PE a - Trailing PE f - Price / NAV b 3.1498
Dividend (USD) d - Cash In Hand (USD) g 0.4833 Issued & Paid-up Shares c 88,108,500
Dividend Yield (%) d - Price / Cash In Hand g 2.711 Treasury Shares h -
Market Cap (M) 115.422 Enterprise Value (M) 84.209
Piotroski F Score 2 Exchange Code XCUR Par Value ( $ ) n.a.
52 Weeks Volatility (%) 69.66 Free Float (%) 65.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 17 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 31 Jul 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EXICURE INC NASDAQ 115.422 - - 3.1498 -
Industry Biotechnology NASDAQ 3,125.715 106.306 106.381 7.1303 0.529
Local Peer MODERNA INC NASDAQ 183,497.472 - 52.505 27.3714 -
Local Peer AMGEN INC NASDAQ 122,116.573 16.811 21.252 14.8073 3.031
Local Peer GILEAD SCIENCES INC NASDAQ 89,885.639 730.785 17.413 4.5620 3.795
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 85,254.498 4,921.093 17.360 13.1119 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 69,147.458 19.682 11.143 4.5710 -
Local Peer ILLUMINA INC NASDAQ 63,550.440 96.876 82.748 12.2684 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 48,017.529 17.708 24.109 5.2213 -
Local Peer BIOGEN INC NASDAQ 43,696.476 10.922 22.781 4.0641 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 35,858.436 - - 9.9422 -
Local Peer SEAGEN INC NASDAQ 30,241.069 49.279 50.632 8.9173 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 22,218.634 - - 26.0365 -
Local Peer BIO-TECHNE CORP NASDAQ 21,067.043 150.131 150.131 13.4788 0.237
Other Local Peers 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NOVAVAX INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), EXELIXIS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), ARVINAS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), VERACYTE INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), INSTIL BIO INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CORTEXYME INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SEER INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), ALECTOR INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), UNIQURE N.V. (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KADMON HLDGS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), OCUGEN INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), ALLOVIR INC (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MAXCYTE INC (NASDAQ), AGENUS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), HUMACYTE INC (NASDAQ), VAXCYTE INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MACROGENICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NUVALENT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DICE THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOATLA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), IMMUNOVANT INC (NASDAQ), NKARTA INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MERUS B V (NASDAQ), IMMATICS N V (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), OMEGA THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), AFFIMED N V (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AADI BIOSCIENCE INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALTIMMUNE INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), PASSAGE BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), EPIZYME INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), 22ND CENTURY GROUP INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), XBIOTECH INC (NASDAQ), AKOUOS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ELIEM THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), HUMANIGEN INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ATYR PHARMA INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IMMUNOME INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), ONCORUS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADICET BIO INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TREVENA INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), MEDICINOVA INC (NASDAQ), NEXTCURE INC (NASDAQ), SYNLOGIC INC (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), CARDIOL THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), SESEN BIO INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), CONTRAFECT CORP (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), IMV INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ARDELYX INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IN8BIO INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), ORGENESIS INC (NASDAQ), ASTRIA THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), INFLARX N V (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), HCW BIOLOGICS INC (NASDAQ), EVOGENE LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ENSYSCE BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ARAVIVE INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ),